Rockefeller Capital Management L.P. Vaxart, Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.67 - $9.8 $3,535 - $5,194	-530 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$5.06 - $10.78 $3,870 - $8,246	-765 Reduced 59.07%	530 $3,000
Q1 2021 May 11, 2021	BUY	$5.64 - $23.33 $4,483 - $18,547	795 Added 159.0%	1,295 $7,000
Q4 2020 Feb 12, 2021	SELL	$3.5 - $7.98 $28,000 - $63,840	-8,000 Reduced 94.12%	500 $2,000
Q2 2020 Aug 12, 2020	BUY	$1.68 - $8.85 $14,280 - $75,225	8,500 New	8,500 $75,000

108

40.6M

96.7K

239K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $115M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.